Fibroblasts in cancer: Unity in heterogeneity
Y Chhabra, AT Weeraratna - Cell, 2023 - cell.com
Tumor cells do not exist in isolation in vivo, and carcinogenesis depends on the surrounding
tumor microenvironment (TME), composed of a myriad of cell types and biophysical and …
tumor microenvironment (TME), composed of a myriad of cell types and biophysical and …
Tumor microenvironment as a therapeutic target in cancer
Y Xiao, D Yu - Pharmacology & therapeutics, 2021 - Elsevier
Tumor microenvironment denotes the non-cancerous cells and components presented in
the tumor, including molecules produced and released by them. The constant interactions …
the tumor, including molecules produced and released by them. The constant interactions …
Diversity and biology of cancer-associated fibroblasts
G Biffi, DA Tuveson - Physiological reviews, 2020 - journals.physiology.org
Efforts to develop anti-cancer therapies have largely focused on targeting the epithelial
compartment, despite the presence of non-neoplastic stromal components that substantially …
compartment, despite the presence of non-neoplastic stromal components that substantially …
Turning foes to friends: targeting cancer-associated fibroblasts
X Chen, E Song - Nature reviews Drug discovery, 2019 - nature.com
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …
IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is poorly responsive to therapies and
histologically contains a paucity of neoplastic cells embedded within a dense desmoplastic …
histologically contains a paucity of neoplastic cells embedded within a dense desmoplastic …
[HTML][HTML] Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
M Orth, P Metzger, S Gerum, J Mayerle, G Schneider… - Radiation …, 2019 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor
prognosis and rising incidence. Late detection and a particularly aggressive biology are the …
prognosis and rising incidence. Late detection and a particularly aggressive biology are the …
Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
Pancreatic cancer is the most lethal common solid malignancy. Systemic therapies are often
ineffective, and predictive biomarkers to guide treatment are urgently needed. We generated …
ineffective, and predictive biomarkers to guide treatment are urgently needed. We generated …
Cancer-associated fibroblasts in gastrointestinal cancer
The tumour microenvironment, also termed the tumour stroma or tumour mesenchyme,
includes fibroblasts, immune cells, blood vessels and the extracellular matrix and …
includes fibroblasts, immune cells, blood vessels and the extracellular matrix and …
[HTML][HTML] Metabolism of pancreatic cancer: paving the way to better anticancer strategies
C Qin, G Yang, J Yang, B Ren, H Wang, G Chen… - Molecular cancer, 2020 - Springer
Pancreatic cancer is currently one of the most lethal diseases. In recent years, increasing
evidence has shown that reprogrammed metabolism may play a critical role in the …
evidence has shown that reprogrammed metabolism may play a critical role in the …
[HTML][HTML] The tumor microenvironment in tumorigenesis and therapy resistance revisited
Simple Summary Tumors are not masses of cancer cells alone but made up of cancer cells,
other cells including fibroblasts, macrophages, endothelial cells, as well as secreted factors …
other cells including fibroblasts, macrophages, endothelial cells, as well as secreted factors …